Aurora Cannabis (NYSE: ACB) reported Q2 revenue of Cdn$67.7 million versus the consensus estimate of Cdn$68.9 million.

• Adjusted EBITDA1 loss was $16.8 million in Q2 2021, which includes termination and restructuring costs of $2.9 million. Excluding restructuring costs and product return provisions, the Company's Adjusted EBITDA loss is $12.1 million.

For earnings history and earnings-related data on Aurora Cannabis (ACB) click here.